Symyx Rejects Certara Bid, Backs Accelrys Offer

Scientific research provider Symyx Technologies rejected a revised buyout proposal by Certara, saying it was not superior to an offer made by Accelrys Inc earlier this year.

On June 17, Certara, and its private equity sponsor Vector Capital, lowered its offer to acquire Symyx to $5.75 a share form its earlier proposal to buy the company for $6.75 a share.

In a statement on Monday, Symyx said Certara's revised proposal was inadequate when considered against the potential value of Symyx as a standalone company. Symyx said the proposal allowed Certara to revoke its proposal before Symyx shareholders could vote, or before the Accelrys agreement was terminated, putting Symyx at risk with potentially no transaction to consummate.

In April, Accelrys had offered to buy Symyx in a stock deal which valued Symyx at a little more than $5 a share, or about $175 million. After the merger, shareholders of each company would own about 50% of the combined entity. Symyx said it reaffirmed its commitment to a merger with Accelrys.

(06/22/2010)

Virtual Event

Digitalization in the Chemical Industry
CHEManager Spotlight

Digitalization in the Chemical Industry

Save the Date: October 22, 2025
The event will be promoted to a combined audience of over 100,000 professionals across Europe through the CHEManager and CITplus networks.

Interview

Specialty Chemicals in a Shifting World
Adapting to Tariffs and Strengthening Regional Networks

Specialty Chemicals in a Shifting World

Jennifer Abril, President & CEO of SOCMA, discusses the impact of new tariffs and the importance of regional supply networks in the specialty chemical industry.

most read

Photo
28.07.2025 • NewsChemistry

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.